TOPIC

PHARMACEUTICALS News & Analysis

Are BioPharma companies the next big tariffs victim?
Stocks
Are BioPharma companies the next big tariffs victim?
We assume that pharmaceutical tariffs will be enacted. While this could bring short-term margin pressure, we have not changed our valuations.
Karen Andersen, CFA | 14 April 2025